Cite
Acute patient‐reported outcomes in B‐cell malignancies treated with axicabtagene ciloleucel.
MLA
Hoogland, Aasha I., et al. “Acute Patient‐reported Outcomes in B‐cell Malignancies Treated with Axicabtagene Ciloleucel.” Cancer Medicine, vol. 10, no. 6, Mar. 2021, pp. 1936–43. EBSCOhost, https://doi.org/10.1002/cam4.3664.
APA
Hoogland, A. I., Jayani, R. V., Collier, A., Irizarry, A. N., Rodriguez, Y., Jain, M. D., Booth, J. M., Hyland, K. A., James, B. W., Barata, A., Bachmeier, C. A., Chavez, J. C., Khimani, F., Krivenko, G. S., Lazaryan, A., Liu, H. D., Nishihori, T., Pinilla, I. J., Shah, B. D., & Abidi, M. (2021). Acute patient‐reported outcomes in B‐cell malignancies treated with axicabtagene ciloleucel. Cancer Medicine, 10(6), 1936–1943. https://doi.org/10.1002/cam4.3664
Chicago
Hoogland, Aasha I., Reena V. Jayani, Aaron Collier, Arroyo, Nathaly Irizarry, Yvelise Rodriguez, Michael D. Jain, Jones, Margaret Booth, et al. 2021. “Acute Patient‐reported Outcomes in B‐cell Malignancies Treated with Axicabtagene Ciloleucel.” Cancer Medicine 10 (6): 1936–43. doi:10.1002/cam4.3664.